Bruker Corporation
BRKR
$35.54
$1.745.15%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -0.41% | 11.04% | 14.64% | 16.37% | 17.42% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.41% | 11.04% | 14.64% | 16.37% | 17.42% |
| Cost of Revenue | 7.40% | 11.90% | 14.50% | 21.93% | 18.07% |
| Gross Profit | -8.31% | 10.18% | 14.78% | 11.17% | 16.77% |
| SG&A Expenses | 4.56% | 15.42% | 17.98% | 28.96% | 23.56% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 62.07% | 143.75% | -861.11% | 278.13% | 190.00% |
| Total Operating Expenses | 6.91% | 14.17% | 14.53% | 27.14% | 21.44% |
| Operating Income | -64.79% | -13.95% | 15.19% | -34.00% | -9.01% |
| Income Before Tax | -95.36% | -64.48% | -77.41% | -53.89% | -69.50% |
| Income Tax Expenses | -119.25% | -56.06% | 9.70% | -51.95% | -19.10% |
| Earnings from Continuing Operations | -44.74% | -67.69% | -93.21% | -54.57% | -86.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 154.55% | -122.22% | 200.00% | -- |
| Net Income | 0.00% | -65.82% | -93.33% | -53.58% | -86.69% |
| EBIT | -64.79% | -13.95% | 15.19% | -34.00% | -9.01% |
| EBITDA | -33.15% | 3.91% | 20.72% | -12.76% | 9.67% |
| EPS Basic | -2.91% | -67.26% | -93.60% | -55.07% | -86.74% |
| Normalized Basic EPS | -70.64% | -26.48% | 12.74% | -39.31% | -8.97% |
| EPS Diluted | 0.00% | -68.57% | -93.58% | -55.00% | -87.15% |
| Normalized Diluted EPS | -70.52% | -26.26% | 12.82% | -39.22% | -8.77% |
| Average Basic Shares Outstanding | 2.85% | 4.41% | 4.19% | 3.34% | 0.41% |
| Average Diluted Shares Outstanding | 2.50% | 4.11% | 4.11% | 3.19% | 0.20% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.01% | 2.09% | 14.62% | 1.21% | 6.92% |